Genetic heart risk? new drug combo aims to stop plaque before it starts
NCT ID NCT05850091
First seen Mar 31, 2026 · Last updated May 23, 2026 · Updated 8 times
Summary
This study tests whether a high-intensity statin and a low-dose anti-inflammatory drug (colchicine) can slow or change the buildup of fatty plaque in the heart arteries. It includes 200 adults aged 40-75 with high genetic risk for heart disease but no symptoms. Participants get a CT scan at the start and after one year to measure plaque changes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.